# Peoples Bancorp of North Carolina Inc: financial statements, quarterly

PEBK · Nasdaq · CIK 1093672 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pebk.md) · [Financials](/companies/pebk/financials.md) · [Filings](/companies/pebk/filings.md) · [Insiders](/companies/pebk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pebk/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $k | [4,966](/filings/0001654954-24-013755.md) | [5,886 d](/filings/0001654954-25-002689.md) | [6,506](/filings/0001654954-25-005121.md) | [6,654](/filings/0001654954-25-008982.md) | [6,918](/filings/0001654954-25-012570.md) | [6,576 d](/filings/0001654954-26-002154.md) | [6,026](/filings/0001654954-26-004543.md) | [6,123](/filings/0001654954-26-007234.md) | [6,286](/filings/0001654954-25-012570.md) | [6,166 d](/filings/0001654954-26-002154.md) | [5,773](/filings/0001654954-26-004543.md) | [5,558](/filings/0001654954-26-007234.md) |
| Income tax | $k | [1,170](/filings/0001654954-24-013755.md) | [984](/filings/0001654954-24-002793.md) | [787](/filings/0001654954-25-005121.md) | [1,386](/filings/0001654954-25-008982.md) | [1,373](/filings/0001654954-25-012570.md) | [1,030 d](/filings/0001654954-26-002154.md) | [1,287](/filings/0001654954-26-004543.md) | [1,503](/filings/0001654954-26-007234.md) | [1,100](/filings/0001654954-25-012570.md) | [2,130 d](/filings/0001654954-26-002154.md) | [1,250](/filings/0001654954-26-004543.md) | [1,496](/filings/0001654954-26-007234.md) |
| Net income | $k | [4,127](/filings/0001654954-24-013755.md) | [3,439](/filings/0001654954-24-002793.md) | [3,948](/filings/0001654954-25-012570.md) | [4,888](/filings/0001654954-25-012570.md) | [3,958](/filings/0001654954-25-012570.md) | [3,559 d](/filings/0001654954-26-002154.md) | [4,345](/filings/0001654954-26-007234.md) | [5,160](/filings/0001654954-26-007234.md) | [3,692](/filings/0001654954-25-012570.md) | [6,633 d](/filings/0001654954-26-002154.md) | [4,398](/filings/0001654954-26-007234.md) | [5,234](/filings/0001654954-26-007234.md) |
| Diluted EPS | $ per share | [0.74](/filings/0001654954-24-013755.md) | [0.62](/filings/0001654954-24-002793.md) | [0.72](/filings/0001654954-25-005121.md) | [0.89](/filings/0001654954-25-008982.md) | [0.72](/filings/0001654954-25-012570.md) | not reported | [0.79](/filings/0001654954-26-004543.md) | [0.95](/filings/0001654954-26-007234.md) | [0.67](/filings/0001654954-25-012570.md) | not reported | [0.80](/filings/0001654954-26-004543.md) | [0.96](/filings/0001654954-26-007234.md) |
| Basic EPS | $ per share | [0.76](/filings/0001654954-24-013755.md) | [0.64](/filings/0001654954-24-002793.md) | [0.74](/filings/0001654954-25-005121.md) | [0.93](/filings/0001654954-25-008982.md) | [0.74](/filings/0001654954-25-012570.md) | not reported | [0.82](/filings/0001654954-26-004543.md) | [0.97](/filings/0001654954-26-007234.md) | [0.70](/filings/0001654954-25-012570.md) | not reported | [0.83](/filings/0001654954-26-004543.md) | [0.98](/filings/0001654954-26-007234.md) |

- Revenue: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [82.4](/filings/0001654954-25-002689.md) | not reported | not reported | [73.2](/filings/0001654954-24-013755.md) | [59.3](/filings/0001654954-26-002154.md) | not reported | not reported | not reported | [58.1](/filings/0001654954-26-007234.md) | [61.3](/filings/0001654954-26-004543.md) | [60.9](/filings/0001654954-26-007234.md) |
| Total assets | $m | [1,607](/filings/0001654954-24-013755.md) | [1,636](/filings/0001654954-25-002689.md) | [1,670](/filings/0001654954-24-005450.md) | [1,655](/filings/0001654954-24-010004.md) | [1,662](/filings/0001654954-24-013755.md) | [1,652](/filings/0001654954-26-002154.md) | [1,693](/filings/0001654954-25-005121.md) | [1,694](/filings/0001654954-25-008982.md) | [1,738](/filings/0001654954-25-012570.md) | [1,702](/filings/0001654954-26-007234.md) | [1,734](/filings/0001654954-26-004543.md) | [1,765](/filings/0001654954-26-007234.md) |
| Total liabilities | $m | [1,500](/filings/0001654954-23-013844.md) | [1,515](/filings/0001654954-25-002689.md) | [1,548](/filings/0001654954-24-005450.md) | [1,531](/filings/0001654954-24-010004.md) | [1,525](/filings/0001654954-24-013755.md) | [1,521](/filings/0001654954-26-002154.md) | [1,554](/filings/0001654954-25-005121.md) | [1,550](/filings/0001654954-25-008982.md) | [1,589](/filings/0001654954-25-012570.md) | [1,545](/filings/0001654954-26-007234.md) | [1,576](/filings/0001654954-26-004543.md) | [1,604](/filings/0001654954-26-007234.md) |
| Shareholders' equity | $m | [107](/filings/0001654954-24-013755.md) | [121](/filings/0001654954-26-002154.md) | [121](/filings/0001654954-25-012570.md) | [124](/filings/0001654954-25-012570.md) | [136](/filings/0001654954-25-012570.md) | [131](/filings/0001654954-26-007234.md) | [139](/filings/0001654954-26-007234.md) | [144](/filings/0001654954-26-007234.md) | [149](/filings/0001654954-25-012570.md) | [157](/filings/0001654954-26-007234.md) | [158](/filings/0001654954-26-007234.md) | [161](/filings/0001654954-26-007234.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [4,188 d](/filings/0001654954-24-013755.md) | [5,715 d](/filings/0001654954-25-002689.md) | [3,669](/filings/0001654954-25-005121.md) | [6,658 d](/filings/0001654954-25-008982.md) | [4,898 d](/filings/0001654954-25-012570.md) | [5,333 d](/filings/0001654954-26-002154.md) | [5,924](/filings/0001654954-26-004543.md) | [5,470 d](/filings/0001654954-26-007234.md) | [4,688 d](/filings/0001654954-25-012570.md) | [5,291 d](/filings/0001654954-26-002154.md) | [5,028](/filings/0001654954-26-004543.md) | [6,436 d](/filings/0001654954-26-007234.md) |
| Capital expenditure | $k | [569 d](/filings/0001654954-24-013755.md) | [426 d](/filings/0001654954-25-002689.md) | [128](/filings/0001654954-25-005121.md) | [87.0 d](/filings/0001654954-25-008982.md) | [212 d](/filings/0001654954-25-012570.md) | [160 d](/filings/0001654954-26-002154.md) | [763](/filings/0001654954-26-004543.md) | [102 d](/filings/0001654954-26-007234.md) | [314 d](/filings/0001654954-25-012570.md) | [234 d](/filings/0001654954-26-002154.md) | [448](/filings/0001654954-26-004543.md) | [397 d](/filings/0001654954-26-007234.md) |
| Dividends paid | $k | [1,058 d](/filings/0001654954-24-013755.md) | [1,056 d](/filings/0001654954-25-002689.md) | [1,929](/filings/0001654954-25-005121.md) | [1,040 d](/filings/0001654954-25-008982.md) | [1,039 d](/filings/0001654954-25-012570.md) | [1,039 d](/filings/0001654954-26-002154.md) | [1,968](/filings/0001654954-26-004543.md) | [1,093 d](/filings/0001654954-26-007234.md) | [1,093 d](/filings/0001654954-25-012570.md) | [1,093 d](/filings/0001654954-26-002154.md) | [2,075](/filings/0001654954-26-004543.md) | [1,147 d](/filings/0001654954-26-007234.md) |
| Share repurchases | $k | [840 d](/filings/0001654954-24-013755.md) | [324 d](/filings/0001654954-25-002689.md) | [1,998](/filings/0001654954-25-005121.md) | [0.0 d](/filings/0001654954-25-008982.md) | [0.0 d](/filings/0001654954-25-012570.md) | [0.0 d](/filings/0001654954-26-002154.md) | [0.0](/filings/0001654954-25-005121.md) | [0.0 d](/filings/0001654954-25-008982.md) | [0.0 d](/filings/0001654954-25-012570.md) | [0.0 d](/filings/0001654954-26-002154.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [5,658](/filings/0001654954-23-013844.md) | [5,656](/filings/0001654954-24-005450.md) | [5.6](/filings/0001654954-24-010004.md) | [5.6](/filings/0001654954-24-013755.md) | [5,501](/filings/0001654954-24-005450.md) | [5.5](/filings/0001654954-25-008982.md) | [5.5](/filings/0001654954-25-012570.md) | [5.5](/filings/0001654954-26-004543.md) | [5.5](/filings/0001654954-26-007234.md) | [5.5](/filings/0001654954-25-012570.md) | [5.5](/filings/0001654954-26-004543.md) | [5.5](/filings/0001654954-26-007234.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 5,461,490 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0001654954-26-007234.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:33 ET. No prices; not investment advice.